scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | J W J Bijlsma | |
J W G Jacobs | |||
E Buskens | |||
H Verkleij | |||
S M M Verstappen | |||
Utrecht Rheumatoid Arthritis Cohort Study Group | |||
E J ter Borg | |||
A A M Blaauw | |||
P2860 | cites work | Update on work disability in rheumatic diseases | Q34165685 |
Labour force participation among patients with rheumatoid arthritis | Q35549454 | ||
Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis | Q35549946 | ||
The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients | Q35550247 | ||
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). | Q35551485 | ||
P433 | issue | 3 | |
P921 | main subject | disability | Q12131 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 488-497 | |
P577 | publication date | 2004-06-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys | |
P478 | volume | 51 |
Q33766367 | 14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage |
Q52632592 | A Systematic Review about the Efficacy and Safety of Tripterygium wilfordii Hook.f. Preparations Used for the Management of Rheumatoid Arthritis. |
Q55100474 | Area of Residence and Socioeconomic Factors Reduce Access to Biologics for Rheumatoid Arthritis Patients in Romania. |
Q23912220 | Beyond return to work: testing a measure of at-work disability in workers with musculoskeletal pain |
Q36773202 | Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis |
Q81658201 | COMET's path, and the new biologicals in rheumatoid arthritis |
Q48915370 | Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis |
Q81658198 | Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial |
Q36810173 | Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. |
Q51906908 | Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial. |
Q33413158 | Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort |
Q26741224 | Economic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal Disease |
Q38780142 | Education and Employment Participation in Young Adulthood. What Role Does Arthritis Play? |
Q42624729 | Effect of Adalimumab on Work Ability Assessed in Rheumatoid Arthritis Disease Patients in Saudi Arabia (AWARDS). |
Q38127400 | Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals |
Q38689012 | Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials |
Q36183792 | Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study |
Q36843031 | Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out. |
Q54486804 | Experiences of employment among young people with juvenile idiopathic arthritis: a qualitative study. |
Q57995059 | Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA |
Q55098455 | Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients. |
Q79772056 | Functional staging and surgical intervention of the elbow and shoulder joints in a patient with rheumatoid arthritis |
Q34805081 | Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts |
Q35579507 | Health economics: implications for novel antirheumatic therapies |
Q31043066 | Health status, activity limitations, and disability in work and housework among Latinos and non-Latinos with arthritis: an analysis of national data |
Q37031429 | Illness intrusion and psychological adjustment to rheumatic diseases: a social identity framework |
Q45279742 | Impact of ankylosing spondylitis on work in patients across the UK. |
Q55018924 | Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. |
Q39257920 | Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. |
Q31019080 | Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. |
Q44373707 | Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis |
Q57146485 | Negotiating disability in everyday life: ethnographical accounts of women with rheumatoid arthritis |
Q37639498 | One Year Effects of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis: Results of a Randomized Controlled Trial |
Q38046771 | Patients with well-established ankylosing spondylitis show limited deterioration in a ten-year prospective cohort study. |
Q35637390 | Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment |
Q80814319 | Physical activity prevents bone loss in premenopausal women with rheumatoid arthritis: a cohort study |
Q34117111 | Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol |
Q38683116 | Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years |
Q89876454 | Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis |
Q31107489 | Prevalence and correlates of arthritis-attributable work limitation in the US population among persons ages 18-64: 2002 National Health Interview Survey Data |
Q35637284 | Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis |
Q47109653 | Prevalence, impact and care of foot problems in people with rheumatoid arthritis: results from a United Kingdom based cross-sectional survey |
Q37140108 | Process Evaluation of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis |
Q35555089 | Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity |
Q50616014 | Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis. |
Q40180629 | Quality of care of rural rheumatoid arthritis patients in Austria |
Q47553009 | Quality of life, sleep and rheumatoid arthritis (QUASAR): a protocol for a prospective UK mHealth study to investigate the relationship between sleep and quality of life in adults with rheumatoid arthritis |
Q46017740 | Randomized prospective study of a work place ergonomic intervention for individuals with rheumatoid arthritis and osteoarthritis. |
Q80229943 | Rheumatoid arthritis: a primer for pharmacists |
Q92092797 | Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study |
Q36166120 | Sick leave and work disability in patients with early arthritis |
Q45272999 | Sick leave as a predictor of job loss in patients with chronic arthritis |
Q33767877 | Sick leave patterns in common musculoskeletal disorders--a study of doctor prescribed sick leave. |
Q35954686 | Socioeconomic and employment status of patients with rheumatoid arthritis in Korea |
Q33984991 | Striking a balance: work-health-personal life conflict in women and men with arthritis and its association with work outcomes |
Q37107862 | Surgery Insight: orthopedic treatment options in rheumatoid arthritis |
Q39904758 | Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. |
Q35683446 | Tension at the borders: perceptions of role overload, conflict, strain and facilitation in work, family and health roles among employed individuals with arthritis |
Q23918715 | The association between rheumatoid arthritis related structural changes in hands and computer keyboard operation |
Q48075422 | The burden of disease in rheumatoid arthritis |
Q37848120 | The burden of illness of rheumatoid arthritis |
Q36885296 | The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort |
Q30836343 | The experience of foot problems and decisions to access foot care in patients with rheumatoid arthritis: a qualitative study. |
Q37251489 | The impact of rheumatoid arthritis and biologics on employers and payers. |
Q50945018 | The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional study. |
Q53234940 | The international classification for functioning, disability and health. A challenge and a need for rheumatology. |
Q37204693 | Thermal rehabilitation and osteoarticular diseases of the elderly |
Q38960132 | Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapy |
Q35065233 | Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry. |
Q53369582 | Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. |
Q33714787 | Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers |
Q51129676 | Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis. |
Q58805834 | Work Ability and Employment in Rheumatoid Arthritis: A Cross-Sectional Study on the Role of Muscle Strength and Lower Extremity Function |
Q48913303 | Work ability: a new outcome measure in rheumatoid arthritis? |
Q57030815 | Work disability and its determinants in patients with pituitary tumor-related disease |
Q37595991 | Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort |
Q40360229 | Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register |
Q36985736 | Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. |
Q51770477 | Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina. |
Q33871651 | Work dynamics among persons with systemic lupus erythematosus |
Q51287268 | Work instability and financial loss in early inflammatory arthritis. |
Q50661536 | Work productivity loss in early arthritis during the first 3 years of disease: a study from a French National Multicenter Cohort. |
Q33990812 | Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. |
Search more.